Protara Therapeutics, Inc. (TARA) stock
TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.32−0.06 (-2.52%)
Close on Nov 17, 2026Market cap $137.10MP/E –Yield –
Protara Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2014 it was -113.4%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | -113.4% | – |
See a number that looks wrong?